We thus further restricted our analyses to the 20 candidates involved in these processes with the addition of two other relevant factors, LECT2 and FETUB, which we identified in our proteomic analysis but, unexpectedly, were not identified by the MetaCore program, despite previous reports highlighthing their role in metabolic diseases [13,14,36,37] (Figure 3C). Here, FETUB is linked to Other metabolic disease.